杭州景曜生物科技

Hangzhou Jingyao Biotechnology is a specialized biotechnology company focused on developing high-throughput drug screening platforms and automated life science instruments. The company integrates microfluidics, computer vision, and zebrafish biological models to provide efficient solutions for early-stage drug discovery and safety evaluation. Their primary products include automated zebrafish imaging systems and microfluidic chips that enable large-scale, standardized phenotypic screening. Jingyao Biotech serves pharmaceutical companies, contract research organizations, and academic institutions, helping to reduce the time and cost associated with drug development. By automating the handling and analysis of zebrafish embryos, the company provides a bridge between in vitro assays and mammalian in vivo studies.